Sources of Medical Technology Universities and Industry (1995) / Chapter Skim
Currently Skimming:
APPENDIX A: WORKSHOP AGENDA
APPENDIX A: WORKSHOP AGENDA
Pages 223-226
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 223... ...
Introduction to the Workshop Enriqueta Bond, Executive Officer, Institute of Medicine SESSION I SETTING THE STAGE Moderator: Ken Melmon, Stanford University Some Further Thoughts on the Origin of the Workshop 3:00 4:00 Medical Innovation and the Economic Environment Victor Fuchs, Stanford University R&D Management: An Academic Perspective Stanley Cohen, Stanford University Institutional Factors Affecting the University-Industry Interface Niels Reimers, Technology Linkages International Discussion 223
|
From page 224... ...
MEDICAL DEVICE INNOVATION Moderator: Bill Hubbard, Former President, The Upjohn Company Respondents: Ben Holmes, Hewlett-Packard; James Benson, Health Industry Manufacturers Association; and Harvey Rudolph, Food and Drug Administration 8:45 10:45 11:00 Minimally Invasive Therapy: The Case of Endoscopy Introduction: Nathan Rosenberg, Stanford University, and Annetine Gelijns, Institute of Medicine/Columbia University Discussion The Laser in Medicine: Birth of a New Industry Introduction: Joanne Spetz, Stanford University Discussion Break Cardiovascular Diagnostics Introduction: Stan Finkelstein, Massachusetts Institute of Technology, Gregory Bell, Charles River Associates, and Kevin Neels, Quintiles Discussion
|
From page 225... ...
WORKSHOP AGENDA 12:00 1:00 Medical Imaging: MRI and PET Introduction: Richard Rettig, Institute of Medicine, Holly Dawkins, Institute of Medicine, and Everette James, Vanderbilt University Discussion Lunch Cochlear Implants Introduction: Stuart Blume, University of Amsterdam Discussion SESSION III. PHARMACEUTICAL AND BIOTEClI INNOVATION Moderator: Stanley Reiser, University of Texas Health Science Center 225 Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association Purine Metabolism and the Development of Chemotherapeutic Agents Introduction: Chris Flowers and Ken Melmon, Stanford University Discussion 4:15 4:30 5:30 Break Innovation in Biotechnology: The Case of the Small Firm Introduction: Alfonso Gambardella, Bocconi University, Milan, and Ashish Arora, Carnegie-Mellon University Discussion Adjoumment
|
From page 226... ...
Moderator: Stanley Reiser, University of Texas Health Science Center Respondents: Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association 8:00 a.m. Innovation in Compounds to Treat Diabetes Introduction: Scott Stern, Stanford University Discussion What Is Public?
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.